1|0|Public
50|$|<b>Quadrosilan</b> (INN, BAN) (trade name Cisobitan; former {{developmental}} {{code name}} KABI-1774) is a synthetic, nonsteroidal estrogen {{that was developed}} in the 1970s and that is or has been used as an antigonadotropic agent in the treatment of prostate cancer. It is an organosilicon compound, and is also known as 2,6-cisdiphenylhexamethylcyclotetrasiloxane. <b>Quadrosilan</b> has estrogenic activity equivalent to that of estradiol, and can produce feminization and gynecomastia as side effects in male patients.|$|E

